BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16:28126-28145. [PMID: 26703566 DOI: 10.3390/ijms161226087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan L, Zeng BM, Liu LL, Ren Y, Yang YQ, Chu J, Li Y, Yang FW, He YH, Lin SD. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection. World J Gastroenterol 2019;25:2327-37. [PMID: 31148904 DOI: 10.3748/wjg.v25.i19.2327] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hung CH, Kee KM, Chen CH, Tseng PL, Tsai MC, Chen CH, Wang JH, Chang KC, Kuo YH, Yen YH, Hu TH, Lu SN. A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation. Clin Transl Gastroenterol 2017;8:e104. [PMID: 28662023 DOI: 10.1038/ctg.2017.29] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
3 El-mesery M, El-mowafy M, Youssef LF, El-mesery A, Abed SY, Elgaml A. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients. Journal of Interferon & Cytokine Research 2021;41:52-9. [DOI: 10.1089/jir.2020.0118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen WL, Lin CH, Huang CC, Tsai CI. Chinese herbal medicine reduces acute hepatitis exacerbation in patients with hepatitis B virus infection: A case-control study in Taiwan. Complement Ther Med 2019;42:248-54. [PMID: 30670249 DOI: 10.1016/j.ctim.2018.11.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang X, Dong P, Xu L, Tian Y, Sun H, Shi H, Duan Z, Chen L, Ren F. The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure. BMC Gastroenterol 2019;19:148. [PMID: 31429707 DOI: 10.1186/s12876-019-1064-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bilgic Y, Akbulut S, Cengiz A, Sarici A, Cagin Y, Harputluoglu M. Therapeutic Effects of Plasmapheresis on Acute Exacerbations of Chronic Hepatitis B Infection. Cureus 2021;13:e12779. [PMID: 33628651 DOI: 10.7759/cureus.12779] [Reference Citation Analysis]
7 Yao X, Yu H, Fan G, Xiang H, Long L, Xu H, Wu Z, Chen M, Xi W, Gao Z, Liu C, Gong W, Yang A, Sun K, Yu R, Liang J, Xie B, Sun S. Impact of the Gut Microbiome on the Progression of Hepatitis B Virus Related Acute-on-Chronic Liver Failure. Front Cell Infect Microbiol 2021;11:573923. [PMID: 33889550 DOI: 10.3389/fcimb.2021.573923] [Reference Citation Analysis]
8 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2019;25:93-159. [PMID: 31185710 DOI: 10.3350/cmh.2019.1002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 32.0] [Reference Citation Analysis]